EQUITY INVESTMENTS (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Feb. 05, 2026 |
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Equity investment, Increase in carrying value | $ 2,786,000 | $ 1,734,000 | |
| Outstanding securities percentage | 2.50% | ||
| Common Stock [Member] | |||
| Number of shares hold | 2,054,507 | ||
| Series A Preferred Stock [Member] | |||
| Number of shares hold | 262,908 | ||
| Series A 1 Preferred Stock [Member] | |||
| Number of shares hold | 319,789 | ||
| Private Placement [Member] | |||
| Issued preferred stock, value | $ 115,000,000 | ||
| Equity investment, Increase in carrying value | $ 1,052,000 | ||
| Equity investment corresponding gain | 1,052,000 | ||
| ILiAD Biotechnologies, LLC [Member] | |||
| Aggregrate investment | $ 7,000,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition This element represents disclosure of the amount of gain which has been deferred as the result of the sale of a business or operating assets to a highly leveraged entity which deferred gain has been reflected in the accompanying statement of financial position as reduction from the related asset. No definition available.
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|